Total raised
—
Last: Seed 2022-09
Stage
Seed
Founded
2022
Headcount
6
HQ
Or Yehuda
Sector
Health Tech & Life Sciences
About
NovaPulse is a bioconvergence company specializing in the multibillion-dollar peripheral artery disease market. The company is focused on helping the millions of claudication patients who suffer from pain and have trouble walking because of insufficient blood supply to their legs.
NovaPulse is the brainchild of the MEDX Xelerator incubator.
Funding history · 1 round · — total
2022-09
Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2CB2B
Tags
bioconvergencecardiologyheart-diseases